Clinical Trial Detail

NCT ID NCT02835729
Title A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin

Cytarabine + Idarubicin + Indoximod

Age Groups: senior adult

No variant requirements are available.